CD274 and breast cancer: In addition, our results also showed that the m6Ascore was significantly correlated with predictors of the immune response such as PD-L1, immunophenoscore, and TIDE, indicating that modification of m6A impacts the therapeutic effect of immunotherapy and is conducive for improving personalized treatment of BC.